Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected]
- PMID: 19901101
- DOI: 10.1200/JCO.2009.24.5985
Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected]
Erratum in
- J Clin Oncol. 2010 Mar 10;28(8):1439
Comment on
-
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.J Clin Oncol. 2009 Dec 10;27(35):5881-6. doi: 10.1200/JCO.2009.24.1034. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901104 Free PMC article. Clinical Trial.
-
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.J Clin Oncol. 2009 Dec 10;27(35):5874-80. doi: 10.1200/JCO.2009.23.6497. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901110 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
